Cited by

• Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer.

  Jiang CY, Zhao L, Green MD, Ravishankar S, Towlerton AMH, Scott AJ, Raghavan M, Cusick MF, Warren EH, Ramnath N. Jiang CY, et al. Sci Rep. 2024 Jan 3;14(1):345. doi: 10.1038/s41598-023-48546-y. Sci Rep. 2024. PMID: 38172168 Free PMC article.
• Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients.

  Nardone V, Reginelli A, De Marco G, Natale G, Patanè V, De Chiara M, Buono M, Russo GM, Monti R, Balestrucci G, Salvarezza M, Di Guida G, D'Ippolito E, Sangiovanni A, Grassi R, D'Onofrio I, Belfiore MP, Cimmino G, Della Corte CM, Vicidomini G, Fiorelli A, Gambardella A, Morgillo F, Cappabianca S. Nardone V, et al. Diagnostics (Basel). 2023 Jan 22;13(3):400. doi: 10.3390/diagnostics13030400. Diagnostics (Basel). 2023. PMID: 36766506 Free PMC article.
• Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms.

  de Filette JMK, André S, De Mey L, Aspeslagh S, Karmali R, Van der Auwera BJ, Bravenboer B. de Filette JMK, et al. BMC Endocr Disord. 2022 Nov 22;22(1):291. doi: 10.1186/s12902-022-01190-5. BMC Endocr Disord. 2022. PMID: 36419114 Free PMC article.
• PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach.

  Fameli A, Nardone V, Shekarkar Azgomi M, Bianco G, Gandolfo C, Oliva BM, Monoriti M, Saladino RE, Falzea A, Romeo C, Calandruccio ND, Azzarello D, Giannicola R, Pirtoli L, Giordano A, Tassone P, Tagliaferri P, Cusi MG, Mutti L, Botta C, Correale P. Fameli A, et al. Front Oncol. 2022 Sep 14;12:911579. doi: 10.3389/fonc.2022.911579. eCollection 2022. Front Oncol. 2022. PMID: 36185285 Free PMC article.
• Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis.

  Nardone V, Giannicola R, Giannarelli D, Saladino RE, Azzarello D, Romeo C, Bianco G, Rizzo MR, Di Meo I, Nesci A, Pastina P, Falzea AC, Caracciolo D, Reginelli A, Caraglia M, Luce A, Mutti L, Giordano A, Cappabianca S, Pirtoli L, Barbieri V, Tassone P, Tagliaferri P, Correale P. Nardone V, et al. Life (Basel). 2021 Nov 15;11(11):1235. doi: 10.3390/life11111235. Life (Basel). 2021. PMID: 34833111 Free PMC article.